A PROCEDURE FOR INCREASNG BLOOD OXYGEN TENSION IN PATIENTS WITH CHRONIC HEART FAILURE

Download full text PDF
Issue: 
11
Year: 
2015

Professor V. Kukes (1), MD, Academician of the Russian Academy of Sciences; Professor A. Prokofyev (1,2), MD; A. Zhestovskaya (1); V. Smirnov (1,2), Candidate of Pharmaceutical Sciences; L. Pavlova (1), Candidate of Medical Sciences; O. Goroshko (2), Candidate of Pharmaceutical Sciences; O. Checha (2), Candidate of Biological Sciences 1 -I.M. Sechenov First Moscow State Medical University 2 -Research Center for Examination of Medical Products, Moscow

2,3-diphosphoglycerate regulating oxyhemoglobin dissociation in the lung plays a large role in the body’s functional system to ensure the optimal level of blood oxygen. Ethylmethylhydroxypyridine malate affects blood oxygen levels, reducing the degree of hypoxia.
Keywords: 
chronic heart failure
2
3-diphosphoglycerate
ethylmethylhydroxypyridine malate
metabolism
hypoxia

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. VOZ. Informatsionnyj bjulleten' №317. Janvar' 2015 g.
  2. Kukes V.G., Starodubtsev A.K. Klinicheskaja farmakologija i farmakoterapija / M: GEOTAR-Media, 2012; s. 308.
  3. Dickstein K., Cohen-Solal A., Filippatos G. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) // Eur. J. Heart Fail. – 2008; 10: 933–89.
  4. Luk'janova L.D. Sovremennye problemy i perspektivy farmakologicheskoj korrektsii gipoksicheskih sostojanij. V kn. Farmakoterapija v nevrologii i psihiatrii / M., 2002; s. 22–34.
  5. Smirnov A.V., Krivoruchko B.I. Antigipoksanty v neotlozhnoj meditsine // Anesteziol. i reanimatol. – 1998; 2: 50–5.
  6. Luk'janchuk V.D., Savchenkova L.V. Antigipoksanty: sostojanie i perspektivy // Eksperim. i klin. farmakol. – 1998; 61 (4): 72–9.
  7. Negovskij V.A., Zolotokrylina E.S. Postreanimatsionnaja bolezn' / M.: Meditsina, 1987; s. 480.
  8. Luk'janova L.D. Novye podhody k sozdaniju antigipoksantov metabolicheskogo dejstvija // Vestnik RAMN. – 1999; 3: 18–25.
  9. Stoljarova V.V. Issledovanie kardioprotektornogo dejstvija preparatov s antioksidantnoj aktivnost'ju pri ostroj ishemii golovnogo mozga // Eksperim. i klin. farmakol. – 2001; 64 (6): 31–3.
  10. Gatsura V.V. Farmakologicheskaja korrektsija energeticheskogo obmena ishemizirovannogo miokarda / M.: Anteks, 1993; 254 s.
  11. Sernov L.N. i dr. Proizvodnye oksipiridinkarbonovyh kislot kak perspektivnyj klass himicheskih soedinenij. Mezhdunarodnaja nauchnaja konferentsija. Ekaterinburg, 1994; 18 s.
  12. Svetlikova I.V. Protivoishemicheskaja aktivnost' nekotoryh proizvodnyh 3-oksipiridina i oksinikotinovoj kisloty. Avtoref. dis. … kand. med. nauk. Kupavna, 1994; 18 s.
  13. Berezovskaja I.V. i dr. Doklinicheskogo issledovanie obschetoksicheskogo dejstvija Etoksidola // Toksikol. vestn. – 2010; 5: 42.
  14. Bajshukurova A.K. Obrazovanie 2,3-DFG v eritrotsitah pri eksperimental'nyh vozdejstvijah, izmenjajuschih uslovija transporta kisloroda. Dis. … kand. biol. nauk. Leningrad, 1983; 135 s.
  15. Rjadovoj G.V. Soderzhanie 2,3-DFG i ego vlijanie na srodstvo k gemoglobinu kisloroda u bol'nyh posle operatsii na otkrytom serdtse // Anesteziol. i reanimatol. – 1990; 5: 31–4.
  16. Kukes V.G., Prokof'ev A.B., Goroshko O.A. i dr. Vlijanie etilmetilgidroksipiridinamalata na naprjazhenie kisloroda v krovi u patsientov s hronicheskoj serdechnoj nedostatochnost'ju // Lekarstvennye sredstva i ratsional'naja farmakoterapija. – 2013; 3: 18–22.
  17. Kargaeva T.N. Izuchenie farmakologicheskoj aktivnosti etoksidola pri oksidativno-toksicheskom serdechno-legochnom porazhenii. Avtoref. dis. … kand. med. nauk. Saransk, 2011; 23 s.